semaglutide dementia study Results from the latest clinical trials show semaglutide, a drug used to treat type 2 diabetes and help with weight loss under the brand names Rybelsus, Ozempic, and Wegovy, does not slow Tirzepatide versus semaglutide for the

The Lancet (2025): Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial.EMC (2026): Wegovy 7.2 mg Solution for injection in pre-filled pen Patient Information Leaflet

Research indicates that a significant change in weight, typically around 5-10% of your body mass, can cause your periods to become irregular or even cease temporarily, a condition known medically as amenorrhea

[47:00] Does GLP-1 increase neurogenesis and neurotrophic factors

However, its vital to collaborate closely with Dr

Consult Your Licensed Healthcare Provider Regularly You shouldnt feel alone if you notice menstrual changes while using semaglutide